Axsome Therapeutics (AXSM) has just broken out of a multi-month descending trendline, signaling renewed bullish momentum. I will buy at the open, targeting the analyst price target of $176.68 for a potential strong upside move. My stop will be set just below the prior resistance line (~$110), which should now act as support. This setup offers a favorable risk/reward, with the trendline breakout confirming renewed interest and upside potential.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。